Welcome to Francis Academic Press

Frontiers in Medical Science Research, 2022, 4(15); doi: 10.25236/FMSR.2022.041507.

Dipotassium Glycyrrhizinate Inhibits Histamine-Induced Proliferation by Suppressing Cell Cycle and P38/FAK Pathway of Lung Cancer Cells In-Vitro


Jialing Tang1, Pinyu Wan1, Xiuwen Li1, Xuejiao Lian1, Guangzhao He2, Xiaoying Zhou3

Corresponding Author:
Xiaoying Zhou

1School of Pharmacy, Changzhou University, Changzhou, 213164, China

2Pharmacy, Changzhou Cancer Hospital, Soochow University, Changzhou, China

3School of Pharmacy, Changzhou University, Changzhou, 213164, China


Histamine is released from activated mast cells which have been found around tumor tissue area. The aim of this study was to examine the function of histamine on human lung cancer cell line A549 cell; to investigate the anti-histamine effects of dipotassium glycyrrhizinate (DG) on histamine mediated proliferation and migration of A549 cells and to explore the potential inhibitory mechanism of DG on lung cancer cell metastasis. The in-vitro histamine/A549 cells model was established, the cell proliferation, migration and cell cycle were examined, and the intracellular glutathione (GSH) level and signal proteins were detected. Data showed that histamine promote cell viability, proliferation and migration, while DG inhibited the histamine-induced cell proliferation and migration. DG decreased histamine-induced expressions of FAK, matrix metalloproteinases-2/9 (MMP-2/9), P38, PCNA, and Bcl-2, and DG up-regulated Bax, P53 and Becline-1 expressions against histamine’s effects. DG altered the histamine-driven M-phase in cell cycle and decreased the histamine-elevated GSH content in A549 cells, leading to cell apoptosis. This study revealed that DG inhibited the histamine-induced cell proliferation and promoted cell apoptosis of A549 cells, implicating its potential therapeutic mechanisms on lung cancer cell proliferation, metastasis and development.


lung cancer; histamine; dipotassium glycyrrhizinate; A549 cell

Cite This Paper

Jialing Tang, Pinyu Wan, Xiuwen Li, Xuejiao Lian, Guangzhao He, Xiaoying Zhou. Dipotassium Glycyrrhizinate Inhibits Histamine-Induced Proliferation by Suppressing Cell Cycle and P38/FAK Pathway of Lung Cancer Cells In-Vitro. Frontiers in Medical Science Research (2022) Vol. 4, Issue 15: 41-49. https://doi.org/10.25236/FMSR.2022.041507.


[1] Georgiou, K., Marinov, B., Farooqi, A.A. and Gazouli, M. (2021) Gut Microbiota in Lung Cancer: Where Do We Stand? International journal of molecular sciences, 22.

[2] Fan, X.X. and Wu, Q. (2022) Decoding Lung Cancer at Single-Cell Level. Front Immunol, 13, 883758.

[3] Tang, X., Sui, X., Weng, L. and Liu, Y. (2021) SNAIL1: Linking Tumor Metastasis to Immune Evasion. Front Immunol, 12, 724200.

[4] Thomas, D. and Radhakrishnan, P. (2019) Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis. Mol Cancer, 18, 14.

[5] Liu, Q.L., Zhang, Z., Wei, X. and Zhou, Z.G. (2021) Noncoding RNAs in tumor metastasis: molecular and clinical perspectives. Cell Mol Life Sci, 78, 6823-6850.

[6] Lichterman, J.N. and Reddy, S.M. (2021) Mast Cells: A New Frontier for Cancer Immunotherapy. Cells, 10.

[7] Gounaris, E., Erdman, S.E., Restaino, C., Gurish, M.F., Friend, D.S., Gounari, F., et al. (2007) Mast cells are an essential hematopoietic component for polyp development. Proc Natl Acad Sci U S A, 104, 19977-19982.

[8] Thangam, E.B., Jemima, E.A., Singh, H., Baig, M.S., Khan, M., Mathias, C.B., et al. (2018) The Role of Histamine and Histamine Receptors in Mast Cell-Mediated Allergy and Inflammation: The Hunt for New Therapeutic Targets. Front Immunol, 9, 1873.

[9] Yuan, H., Ji, W.S., Wu, K.X., Jiao, J.X., Sun, L.H. and Feng, Y.T. (2006) Anti-inflammatory effect of Diammonium Glycyrrhizinate in a rat model of ulcerative colitis. World J Gastroenterol, 12, 4578-4581.

[10] Li, Y., Liu, T., Yan, C., Xie, R., Guo, Z., Wang, S., et al. (2018) Diammonium Glycyrrhizinate Protects against Nonalcoholic Fatty Liver Disease in Mice through Modulation of Gut Microbiota and Restoration of Intestinal Barrier. Mol Pharm, 15, 3860-3870.

[11] Bonafé, G.A., Dos Santos, J.S., Ziegler, J.V., Umezawa, K., Ribeiro, M.L., Rocha, T., et al. (2019) Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-κB Signaling Pathway. Front Cell Neurosci, 13, 216.

[12] Stoyanov, E., Uddin, M., Mankuta, D., Dubinett, S.M. and Levi-Schaffer, F. (2012) Mast cells and histamine enhance the proliferation of non-small cell lung cancer cells. Lung Cancer, 75, 38-44.

[13] Jiang, Y., Wu, Y., Hardie, W.J. and Zhou, X. (2017) Mast cell chymase affects the proliferation and metastasis of lung carcinoma cells in vitro. Oncol Lett, 14, 3193-3198.

[14] Sun, Z., Wei, T. and Zhou, X. (2018) Liposomes encapsulated dimethyl curcumin regulates dipeptidyl peptidase I activity, gelatinase release and cell cycle of spleen lymphocytes in-vivo to attenuate collagen induced arthritis in rats. Int Immunopharmacol, 65, 511-521.

[15] Huang, W. and Zhou, X. (2022) Anti-histamine effects of dipotassium glycyrrhizinate on lung fibroblasts, implicating its therapeutic mechanism for pulmonary fibrosis. J Pharm Pharmacol, 74, 1241-1250.

[16] Huang, W., He, Y. and Zhou, X. (2022) Dipotassium Glycyrrhizinate Against Fibrotic Effects of Histamine Depletes Intracellular Glutathione to Discomfort Mitochondrial, Inducing Cell Apoptosis/ Ferroptosis of Over-Activated Lung Fibroblast. International Journal of Frontiers in Medicine, 4.0.

[17] Maik-Rachline, G., Wortzel, I. and Seger, R. (2021) Alternative Splicing of MAPKs in the Regulation of Signaling Specificity. Cells, 10.

[18] Marei, H.E., Althani, A., Afifi, N., Hasan, A., Caceci, T., Pozzoli, G., et al. (2021) p53 signaling in cancer progression and therapy. Cancer Cell Int, 21, 703.

[19] Lu, Z., Xiao, Y., Liu, X., Zhang, Z., Xiao, F. and Bi, Y. (2017) Matrine reduces the proliferation of A549 cells via the p53/p21/PCNA/eIF4E signaling pathway. Molecular medicine reports, 15, 2415-2422.

[20] Juríková, M., Danihel, Ľ., Polák, Š. and Varga, I. (2016) Ki67, PCNA, and MCM proteins: Markers of proliferation in the diagnosis of breast cancer. Acta Histochem, 118, 544-552.

[21] Arbel, M., Choudhary, K., Tfilin, O. and Kupiec, M. (2021) PCNA Loaders and Unloaders-One Ring That Rules Them All. Genes (Basel), 12.

[22] Cancer Cell IntYuan, Z., Dewson, G., Czabotar, P.E. and Birkinshaw, R.W. (2021) VDAC2 and the BCL-2 family of proteins. Biochem Soc Trans, 49, 2787-2795.

[23] Alam, M., Alam, S., Shamsi, A., Adnan, M., Elasbali, A.M., Al-Soud, W.A., et al. (2022) Bax/Bcl-2 Cascade Is Regulated by the EGFR Pathway: Therapeutic Targeting of Non-Small Cell Lung Cancer. Front Oncol, 12, 869672.

[24] Gupta, R., Ambasta, R.K. and Pravir, K. (2021) Autophagy and apoptosis cascade: which is more prominent in neuronal death? Cell Mol Life Sci, 78, 8001-8047.

[25] Nikolov, A. and Popovski, N. (2021) Role of Gelatinases MMP-2 and MMP-9 in Healthy and Complicated Pregnancy and Their Future Potential as Preeclampsia Biomarkers. Diagnostics (Basel), 11.

[26] Das, S., Amin, S.A. and Jha, T. (2021) Inhibitors of gelatinases (MMP-2 and MMP-9) for the management of hematological malignancies. Eur J Med Chem, 223, 113623.

[27] Chuang, H.H., Zhen, Y.Y., Tsai, Y.C., Chuang, C.H., Hsiao, M., Huang, M.S., et al. (2022) FAK in Cancer: From Mechanisms to Therapeutic Strategies. International journal of molecular sciences, 23.

[28] Bansal, A. and Simon, M.C. (2018) Glutathione metabolism in cancer progression and treatment resistance. J Cell Biol, 217, 2291-2298.

[29] Traverso, N., Ricciarelli, R., Nitti, M., Marengo, B., Furfaro, A.L., Pronzato, M.A., et al. (2013) Role of glutathione in cancer progression and chemoresistance. Oxid Med Cell Longev, 2013, 972913.